相关实验视频

Updated: Mar 15, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

望远镜式心血管支架方法抑制了高脂核心斑块病变的心血管支架中的斑块突起

Masashi Kotsugi¹, Ichiro Nakagawa², Shohei Yokoyama¹

¹Department of Neurosurgery, Nara Medical University, Kashihara, Japan.

Journal of neurointerventional surgery

|May 22, 2025

概括

望远镜式心脏动脉支架 (TCS) 在心脏动脉支架 (CAS) 期间显著减少高脂核斑块 (LCPs) 的患者的斑块突起. 这种新的方法通过最小化与标准支架技术相关的风险来提高安全性.

科学领域:

心血管医学心血管医学
干预心脏病学干预心脏病学
医疗成像医学成像

背景情况:

Carotid 脂质核心斑块 (LCP) 可以通过近红外光谱学 (NIRS) 来识别.
使用双层支架的关动脉支架 (CAS) 可能导致斑块突起和血栓栓塞事件.

研究的目的:

为了评估望远镜耳支架 (TCS) 方法是否能减少高LCP患者在CAS期间的斑块突起.
在高风险患者中,与标准支架相比,评估TCS的疗效.

主要方法:

研究了63名患有高LCP (最大脂质核心负荷指数>400) 的患者,他们使用双层支架接受了CAS.
在两个不同时期的标准CAS和TCS方法之间的比较.
NIRS和血管内超声波 (IVUS) 用于评估最小光区域 (max-LCBI_MLA) 和斑块突起的最大脂质核心负荷指数.

主要成果:

经过气球血管造形术后的TCS导致显著较小的最小光线区域 (9.2±1.5 mm2对比11.7±3.5 mm2).
最小光面积的变化比率在TCS (2.2±0.6对2.8±1.1) 时明显较小.
使用TCS消除了斑块突起 (0%与标准方法的20%相比,P=0.008).

结论:

望远镜性带支架 (TCS) 方法有效地抑制高LCPs接受CAS的患者的斑块突起.
TCS提供了一种潜在的更安全的替代方案,用于支架高风险的动脉病变.

关键词:

斑块斑块斑块斑块斑块斑块狭窄症 (英语:Stenosis) 是一种缩小症.支架是一种支架.

更多相关视频

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

相关概念视频

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...